Q-omics provides the consensus-scored RN7SL309P profile across patient tissues and cancer cell-line models. RN7SL309P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RN7SL309P RNA expression shows 6,146 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where RN7SL309P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RN7SL309P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RN7SL309P survival associations across molecular data types. RN7SL309P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RN7SL309P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	12	LIHC (108)	view →

This table ranks reproducible RN7SL309P RNA expression–survival associations across cancer types. High RN7SL309P expression shows unfavorable associations in LIHC, BRCA, UCEC, KIRC and LUAD, but favorable associations in OV. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for RN7SL309P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.087	0.555	<.001	108	view →
OV	DFS	Tertile	All	0.515	0.365	.021	48	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
UCEC	DFS	Tertile	III,IV	0.538	0.809	.012	36	view →
KIRC	OS	Tertile	All	0.428	0.652	<.001	24	view →
LUAD	OS	Tertile	IV	0.153	0.714	.012	18	view →

Pink = unfavorable, green = favorable. all 12 lineages →

RN7SL309P-LIHC (DFS)

Kaplan–Meier survival curve for RN7SL309P RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RN7SL309P in patient tissues and cancer cell lines. In patient samples, RN7SL309P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,146	STAD (5786)	view →
RNA	3,641	LUAD (779)	view →